Final Program and Schedule

EDUCATIONAL WORKSHOPS

1:00 p.m.-3:00 p.m.

• WORKSHOP 1: ISSUES IN THE MEASUREMENT OF DISPARITIES IN POPULATIONS
  Chairperson: Marianne Berwick, University of New Mexico Health Sciences Center, Albuquerque, NM

  
  What Happens If We Don't Have Evidence-based Methods to Measure Improvement in Health Disparities?
  Marianne Berwick

  Measurement of Socioeconomic Status in Health Disparities Research
  Vickie L. Shavers, National Cancer Institute, Bethesda, MD

  Issues in the Assessment of Disparities: Deconstructing African American / White Disparities in Breast Cancer Outcomes
  Beth A. Jones, Yale School of Medicine, New Haven, CT

• WORKSHOP 2: TISSUE IS THE ISSUE
  Chairperson: Barbara B. Kavanagh, Arizona Myeloma Network, Glendale, AZ

  
  Tissue is the Issue: The Role of Cancer Patients in the Search for a Cure!
  Barbara B. Kavanagh
  
  The Importance of High-quality Biospecimens to the Research Enterprise: The Road to Molecular Medicine
  Carolyn Compton, National Cancer Institute, Bethesda, MD

  Cancer Research and Policy Issues in American Indian Populations
  Don Warne, Arizona State University, Tempe, AZ
  

EDUCATIONAL WORKSHOPS

3:15 p.m.-5:15 p.m.

• WORKSHOP 3: NEXT GENERATION TECHNOLOGIES AND THEIR USE TO ADDRESS CANCER RELATED DISPARITIES
  Chairperson: Patricia A. Thompson, University of Arizona, Tucson, AZ

  
  Introduction
  Patricia A. Thompson
  
  Consideration of Genetic Diversity and Population Substructure in Whole Genome Association Studies of Complex Diseases
  Meredith Yeager, National Cancer Institute, Bethesda, MD

  High-throughput Sequencing and Resequencing Technologies and Their Application to Disparities Research
  Patricia A. Thompson
  
  The Ethical Implications of Next Generation Technologies to Stratify by Race
  Sandra Soo-Jin Lee, Stanford University Medical School, Palo Alto, CA
  
  
• WORKSHOP 4: METHODS FOR COMMUNITY-BASED INTERVENTIONS
  Chairperson: Moon S. Chen, Jr., University of California Davis Cancer Center, Sacramento, CA

  
  Reducing Cancer Health Disparities through Community-Centered Interventions: Overview
  Moon S. Chen, Jr.
  
  Conceptual Framework for Community Interventions to Reduce Cancer Health Disparities
  Roshan Bastani, University of California School of Public Health, Los Angeles, CA

  Methodological Issues and Tools for Community-Based Trials to Reduce Cancer Health Disparities
  Annette E. Maxwell, University of California, Los Angeles, CA

  Research and Statistical Design Issues in Interventions to Reduce Cancer Health Disparities
  Susan Stewart, University of California, Helen Diller Comprehensive Cancer Center, San Francisco, CA

  Reducing Cancer Health Disparities through a Targeted Media Campaign to Promote Hepatitis B Screening among Vietnamese Americans
  Tung Nguyen, University of California, San Francisco, CA

OPENING PLENARY SESSION

7:00 p.m.-8:00 p.m.

Keynote Presentation: Genomic Medicine in Mexico: New Opportunities and Challenges on the Horizon
Gerardo Jimenez-Sanchez, Instituto Nacional de Medicina Genómica, Mexico City, Mexico

OPENING RECEPTION

8:00 p.m.-10:00 p.m.

SPECIAL SESSION: TRANSDISCIPLINARY SCIENCE IN THE CENTERS FOR POPULATION HEALTH AND HEALTH DISPARITIES (CPHHD) INITIATIVE

Chairperson: Shobha Srinivasan, National Cancer Institute, Rockville, MD
7:00 a.m.-8:00 a.m.

Transdisciplinary Science and the CPHHD Initiative: Introduction
Shobha Srinivasan

Transdisciplinary Science to Understand Disparities in Prostate Cancer
Timothy R. Rebbeck, University of Pennsylvania, Philadelphia, PA

Transdisciplinary Science to Understand Disparities in Cervical Cancer
Electra D. Paskett, Ohio State University Comprehensive Cancer Center, Columbus, OH

Transdisciplinary Science and the CPHHD Initiative: Lessons Learned and Future Directions
Richard B. Warnecke, University of Illinois Cancer Center, Chicago, IL

PLENARY SESSION 1: GENETIC DETERMINANTS OF CANCER - FROM SOUP TO NUTS

Chairperson: Matthew L. Freedman, Dana-Farber Cancer Institute, Boston, MA
8:00 a.m.-10:00 a.m.

Overview
Matthew L. Freedman, Dana-Farber Cancer Institute, Boston, MA

Human Variation
Rick A. Kittles, University of Chicago, Chicago, IL

Molecular Technologies for Detecting Variation
John D. Carpten, TGen, Phoenix, AZ

Statistics for Detecting Associations between Genetic Variants and Cancer
Joan E. Bailey-Wilson, National Human Genome Research Institute, Baltimore, MD

Examples and Case Study of a GWAS for Cancer Predisposition Genes in an Underrepresented Population
Matthew L. Freedman, Dana-Farber Cancer Institute, Boston, MA

Implications for Genetic Testing: The Future
Lawrence C. Brody, National Human Genome Research Institute, Bethesda, MD

PLENARY SESSION 2: RAISING CULTURE AS A PRIORITY IN CANCER INTERVENTION RESEARCH

Chairperson: Amelie G. Ramirez, University of Texas Health Science Center, San Antonio, TX
10:30 a.m.-12:30 p.m.

Behavioral Theory in a Diverse Society
Rena J. Pasick, University of California, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

The Use of Cultural Variables in Communications Promoting Cancer Screening Among African Americans
Vetta L. Sanders Thompson, Washington University in St. Louis, George Warren Brown School of Social Work, St. Louis, MO

Considerations of Culture in Behavior Change Interventions
Usha Menon, University of Illinois, Chicago, IL

CONCURRENT SESSIONS

2:00 p.m.-4:00 p.m.

• SESSION 1: CHALLENGES AND OPPORTUNITIES IN REDUCING DISPARITIES FROM CANCERS OF INFECTIOUS ORIGINS
  Chairperson: Moon S. Chen, Jr., University of California Davis Cancer Center, Sacramento, CA

  
  Challenges and Opportunities in Reducing Disparities Posed by Hepatitis Viruses
  Moon S. Chen, Jr.

  Challenges and Opportunities in Reducing Disparities Posed by Human Papillomavirus
  Silvia Franceschi, International Agency for Research on Cancer, Lyon, France

  Opportunities in Reducing Stomach Cancers Associated with H. pylori
  Duane T. Smoot, Howard University, Washington, DC

• SESSION 2: EARLY DETECTION AND SCREENING
  Co-Chairpersons: Lucile L. Adams-Campbell, Lombardi Comprehensive Cancer Center at Georgetown University, Washington, DC, and Marcia R. Cruz-Correa, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR

  
  Overview
  Lucile L. Adams-Campbell
  
  Racial and Ethnic Disparities in Colorectal Cancer Screening and Surveillance
  Marcia R. Cruz-Correa

  Fostering Informed Decisions about Prostate Cancer Screening among African American and Caucasian Men
  Kathryn L. Taylor, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC
  
  Disparities in Cervical Cancer Screening in the Hispanic Community
  Guillermo Tortolero-Luna, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR
  
  Features of the Metabolic Syndrome and Prostate Cancer in Mexican-Americans: A Population-based Case-control Study
  David S. Lopez, Johns Hopkins University, Baltimore, MD
  

POSTER SESSION A

4:00 p.m.-6:30 p.m.

SPECIAL SESSION: SECONDARY DATA ANALYSIS OF NATIONAL AND STATE HEALTH SURVEY DATA: ACCESS, ANALYSIS, AND FUNDING

Chairperson: Richard P. Moser, National Cancer Institute, Bethesda, MD
7:00 a.m.-8:00 a.m.

Secondary Data Analysis of National and State Health Survey Data: Access and Analysis
Richard P. Moser

Secondary Data Analysis of National and State Health Survey Data: Funding
Amy Lazarus Yaroch, National Cancer Institute, Bethesda, MD

PLENARY SESSION 3: RACIAL AND ETHNIC VARIATIONS IN THE MOLECULAR PROFILES OF CANCER: THE FOUNDATION FOR CLASSIFICATION AND THERAPEUTIC TARGETING

Chairperson: Cheryl L. Willman, University of New Mexico Cancer Center, Albuquerque, NM
8:00 a.m.-10:00 a.m.

Population Differences in the Molecular Pathology of Colorectal Carcinoma
Stanley R. Hamilton, UT M.D. Anderson Cancer Center, Houston, TX

Classification of Breast Cancer Based on Morphologic, Molecular, and Transcriptional Patterns Across Distinct Ethnic Populations
Aysegul A. Sahin, UT M.D. Anderson Cancer Center, Houston, TX

Racial and Ethnic Differences in Leukemia Risk and Leukemia Molecular Profiles: New Insights for Targeted Therapies
Cheryl L. Willman, University of New Mexico Cancer Center, Albuquerque, NM

*Identification of a Novel Candidate Prostate Cancer Susceptibility Gene, Phosphoserine Phosphatase Homologue, in African American Men
Tiffany A. Wallace, National Cancer Institute, Bethesda, MD

*Characterization of Germline Genetic Variants Underlying Racial Disparities of Childhood Leukemia Outcome
Jun J. Yang, St. Jude Children's Research Hospital, Memphis, TN

POSTER SESSION B

10:00 a.m.-12:30 p.m.

PLENARY SESSION 4: BIOLOGY, BEHAVIOR, AND THE PHYSICAL ENVIRONMENT: EXPLORING INTERACTIONS TO ADDRESS HEALTH DISPARITIES

Chairperson: Electra D. Paskett, Ohio State University Comprehensive Cancer Center, Columbus, OH
2:00 p.m.-4:00 p.m.

Multi-level Factors and Cervical Cancer Risk in Appalachia Ohio
Electra D. Paskett

Bio-behavioral Interventions to Reduce Stress Among Multi-ethnic Cancer Patients
Frank J. Penedo, University of Miami, Coral Gables, FL

Communication-based Strategies to Eliminate Cancer Disparities
Matthew Kreuter, Washington University in St. Louis, St. Louis, MO

CONCURRENT SESSIONS

4:15 p.m.-6:15 p.m.

• SESSION 3: A SAMPLING OF CANCER SURVIVORSHIP RESEARCH - NEW FINDINGS AND FUTURE DIRECTIONS
  Chairperson: Diana D. Jeffery, National Cancer Institute, Bethesda, MD

  
  Viewpoint: Past, Current, and Future Health Disparities Research in Cancer Survivorship
  Diana D. Jeffery

  Leveraging Community Health Models to Impact Disparities
  Mollie M. Williams, Susan G. Komen for the Cure, Dallas, TX

  Long-term Outcomes of Prostate Cancer Survivors
  Martin G. Sanda, Beth Israel Deaconess Medical Center, Boston, MA

  Patient, Provider, and Organizational Barriers to Receipt of Depression Care among Low-income Minority Patients with Cancer
  Kathleen R. Ell, University of California, Los Angeles, CA

  *Forgoing Medical Care Because of Cost: Assessing Disparities in Health Care Access Among Cancer Survivors Living in the United States
  Kathryn E. Weaver, National Cancer Institute, Bethesda, MD

• SESSION 4: NEW APPROACHES TO UNDERSTANDING BIOLOGY AND THE ENVIRONMENT IN HEALTH DISPARITIES
  Chairperson: Timothy R. Rebbeck, University of Pennsylvania School of Medicine, Philadelphia, PA

  
  Genetic and Neighborhood Influences in Determining Cancer Disparities
  Timothy R. Rebbeck

  Breast Cancer, Early Development and the Environment: A Transdisciplinary Approach
  Robert A. Hiatt, University of California, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  Relationships Between Neighborhood Characteristics, Stress Related Biomarkers, and Viral Reactivation in the Texas City Stress and Health Study
  M. Kristen Peek, University of Texas Medical Branch, Galveston, TX

  *Increased Odds of Family History for Triple Negative Breast Cancer in Mexican American but Not African American Women
  Betsy C. Wertheim, University of Arizona, Tucson, AZ
  
  *Breast Cancer Risk Factors in U.S.-born and Foreign-born Hispanic Women from the San Francisco Bay Area
  Esther M. John, Northern California Cancer Center, Fremont, CA

CONFERENCE BANQUET

7:00 p.m.-9:00 p.m.

PLENARY SESSION 5: THE SCIENCE BEHIND CERVICAL CANCER DISPARITIES

Chairperson: Francisco A. R. Garcia, University of Arizona, Tucson, AZ
8:00 a.m.-10:00 a.m.

Getting the Most Bang for the Buck: How Our Understanding of HPV Can Inform Cervical Cancer Prevention Strategies
Philip E. Castle, National Cancer Institute, Bethesda, MD

Molecular Markers of HPV-related Disease Progression: Future Directions, Controversies and Dead Ends?
Cosette M. Wheeler, University of New Mexico, Albuquerque, NM

The Science of Community Outreach in Cervical Cancer Prevention and Control
Isabel Scarinci, University of Alabama, Birmingham, AL

Why the New Primary and Secondary Prevention Strategies Will Not Eliminate Cervical Cancer Disparities
Francisco A. R. Garcia

PLENARY SESSION 6: THE SCIENCE OF RECRUITMENT OF UNDERREPRESENTED POPULATIONS TO CLINICAL TRIALS

Chairperson: Jean G. Ford, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
10:30 a.m.-12:30 p.m.

Recruiting African American Men to Cancer Clinical Trials: Lessons Learned
Marvella E. Ford, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC

Lessons Learned through the Minority-Based Community Clinical Oncology Program
Howard A. Zaren, Nancy N. and J.C. Lewis Cancer & Research Pavilion, Savannah, GA

Interventions to Increase Accrual to Cancer Therapeutic Trials: What Do We Know? What Do We Need to Know?
Mollie W. Howerton, Johns Hopkins School of Medicine, Baltimore, MD

Where Do We Go from Here?
Jean G. Ford, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

*Recruiting Diverse Patients to Therapeutic Trials: A Comparison of Three Clinical Settings
Daniel Dohan, University of California, San Francisco, CA

CLOSING REMARKS

12:30 p.m.-12:45 p.m.

DEPARTURE